Representatives Dave Reichert (R-WA), Jim Matheson (D-UT), Pete Olson (R-TX) and Bill Pascrell (D-NJ) have introduced the Medicare Access to Radiology Care Act of 2013 (H.R. 1148).

This bill would amend the Social Security Act to recognize radiologist assistants (RAs) as non-physician providers of healthcare services to Medicare beneficiaries, and it would authorize physician reimbursement through the Centers for Medicare & Medicaid Services (CMS) for procedures performed by RAs in states that have laws establishing radiologist assistant practice guidelines.

With RayStation 3.5, RaySearch releases tools for treatment planning of radiation therapy with electrons and protons, complementing RayStation’s tools for planning and optimization of radiation therapy with photons. Proton Beam Design is a brand new module in RayStation that contains tools for treatment planning of double scattered and uniformly scanned protons, such as a clinically approved Pencil Beam dose engine and automatic generation of treat-and-protect beams.

Royal Philips Electronics is introducing three new imaging systems to help radiology departments increase both the number of patients and range of clinical exams they can handle. Showcased at the 2013 European Congress of Radiology (ECR 2013), all three systems combine the capabilities for high patient throughput with the functionality and advanced clinical imaging applications.

Invivo and iCAD Inc. announced the companies have entered into a global research, development and commercial agreement.  

Under the agreement, iCAD will develop advanced magnetic resonance imaging (MRI) analysis software products, which Invivo will incorporate into its suite of MRI product solutions for global commercial sale.

Lantheus Medical Imaging Inc. announced a new supply contract with the Institute for Radioelements (IRE) to receive a supply of molybdenum-99 (Mo-99), the parent isotope of technetium-99m (Tc-99m), for use in its TechneLite (Technetium Tc 99m Generator) generators.

Two new 1.5T MRI scanners from GE Healthcare, the Optima MR360 Advance and Brivo MR355 Inspire, have recently received 510(k) clearance. Redesigned with new enclosures symbolizing GE’s Humanizing MRI strategy, both systems are engineered to address the demand for increased performance and reduced total cost of ownership for the facility, while providing a comfortable experience for the patient.

Navidea Biopharmaceuticals Inc. announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek (technetium Tc 99m tilmanocept) Injection, a novel product indicated for use in lymphatic mapping procedures to assist in the localization of lymph nodes draining a primary tumor in patients with breast cancer or melanoma. Lymphoseek is a receptor targeted radiopharmaceutical designed to identify these lymph nodes, which have the highest probability of harboring cancer and thereby assist physicians in the staging of such patients.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now